|
|||||
|
|
Targeted Therapies in Triple-Negative Breast Cancer |
|
| Authors: | Frederik Marmé Andreas Schneeweiss |
| Affiliation: | aUniversitäts-Frauenklinik, University of Heidelberg, Germany;bNational Centre for Tumour Diseases, University of Heidelberg, Germany |
| Abstract: | |
| Keywords: | Triple-negative breast cancer Subtypes PARP inhibitors Immune-checkpoint inhibitors Targeted therapy Bevacizumab |